PGIMER chandigarh started clinical trial of Sepsivac on asymptomatic coronavirus patients after the General Drug Controller of India (DGCI) has approved for human trials.
source https://www.pharmatutor.org/pharma-news/2020/pgimer-starts-clinical-trial-of-sepsivac%2C-coronavirus-vaccine
No comments:
Post a Comment